Lilly inks AdvanCell deals to expand in radiopharma
11 Feb 2025 //
BUSINESSWIRE
Lilly inks OliX deals to expand in MASH
11 Feb 2025 //
BUSINESSWIRE
Teva agrees with Axsome to keep generic off market until 2038
11 Feb 2025 //
FIERCE PHARMA
Incyte`s downbeat annual sales of skin disease drug, shares fall
11 Feb 2025 //
REUTERS
Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand
11 Feb 2025 //
REUTERS
Boehringer widens fibrosis drug`s potential after 2nd ph. 3 win
11 Feb 2025 //
PRESS RELEASE
FDA amplifies BD atherectomy safety alert following 4 deaths
11 Feb 2025 //
FDA
Merck in advanced talks to acquire US biotech firm SpringWorks
11 Feb 2025 //
REUTERS
Lupin receives approval from FDA for Ipratropium Br Nasal Solution
11 Feb 2025 //
INDPHARMAPOST
Drugs In Development
![read-more](https://www.pharmacompass.com/image/open-fully.png?v=3)
Market Intel
![read-more](https://www.pharmacompass.com/image/open-fully.png?v=3)